Login to Your Account

XOMA, Takeda In Antibody Deal With $100M Potential

By Jennifer Boggs

Friday, November 3, 2006
XOMA Ltd. could receive more than $100 million in a collaboration with Takeda Pharmaceutical Co. Ltd. to discover and develop monoclonal antibody therapeutics. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription